Exhibit 31.2

I, Andrew Norstrud, certify that:

   1.  I have reviewed this annual report on Form 10-KSB of Stem Cell Therapy
International, Inc.

     2.   Based on my knowledge,  this annual report does not contain any untrue
statement  of a  material  fact  or  omit to  state  a  material  fact necessary
to make the statements  made, in light of circumstances under which such
statements were made, not misleading with respect to the period covered by this
annual report;

     3.   Based on my knowledge, the consolidated financial statements, and
other financial information  included in this  annual  report,  fairly  present
in all material respects the consolidated financial  condition,  consolidated
results of operations and consolidated cash flows of the registrant as of, and
for, the periods  presented in this annual report;

     4.   The registrant's  other certifying  officers and I are responsible for
establishing  and maintaining  disclosure  controls and procedures (as defined
in Exchange  Act Rules  13a-15(e) and 15d-15(e)) and internal controls over
financial reporting (as defined in Exchange Act Rules 13a - 15(f) and 15d -
15(f)) for the  registrant and have:

          a)   designed such  disclosure  controls and procedures, or caused
such disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, included its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

          b)   designed such internal control over financial reporting, or
caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles.

          c)   evaluated the effectiveness of the registrant's disclosure
controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation;

          d)   disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the registrant's most
recent fiscal quarter and year that has materially affected, or is reasonably
likely to materially affect, the registrant's internal control over financial
reporting; and

     5.   The registrant's other certifying officers and I have disclosed, based
on our most recent  evaluation of internal control over financial reporting,  to
the registrant's  auditors and the audit  committee  of  registrant's  board  of
directors  (or  persons performing the equivalent functions):

a)     all  significant  deficiencies and material weaknesses in the  design  or
operation  of internal control over financial reporting which are reasonably
likely to affect the registrant's ability to record,  process,  summarize and
report financial information; and

b)     any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.

                         Chief Financial Officer and
/s/ Andrew Norstrud      Chief Accounting Officer        July 14, 2008
-------------------      ----------------------------    -------------